Fluorescent ligand for human progesterone receptor imaging in live cells

Bioconjugate Chemistry

Volumn 24, Issue 5, 2013, Pages 766-771

  Weinstain, Roy ^a   Kanter, Joan ^a   Friedman, Beth ^a   Ellies, Lesley G ^a   Baker, Michael E ^a   Tsien, Roger Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIES; FLUORESCENCE; POSITRON EMISSION TOMOGRAPHY; PROTEINS; TISSUE;

BORON DIPYRROMETHENE; HEAT-SHOCK PROTEIN 90; HYDROPHILICS; IMMUNOPHILINS; LIVE CELL; MIFEPRISTONE; NUCLEAR TRANSLOCATIONS; PROGESTERONE RECEPTOR; RECEPTOR ANTAGONISTS; TISSUE DISTRIBUTIONS;

LIGANDS;

ALKALINE PHOSPHATASE; BORON DIPYRROMETHENE; DYE; HEAT SHOCK PROTEIN 90; IMMUNOPHILIN; MIFEPRISTONE; PROGESTERONE RECEPTOR; TETRAMETHYLRHODAMINE; UNCLASSIFIED DRUG; 4,4-DIFLUORO-4-BORA-3A,4A-DIAZA-S-INDACENE; BORON DERIVATIVE; FLUORESCENT DYE; HORMONE ANTAGONIST;

ACETYLATION; ARTICLE; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER CELL; DIMERIZATION; DISSOCIATION; DNA BINDING; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; IN VIVO STUDY; LIGAND BINDING; MAMMAL CELL; MOLECULAR DOCKING; MOLECULAR MODEL; POSITRON EMISSION TOMOGRAPHY; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION; ANTAGONISTS AND INHIBITORS; BREAST; BREAST TUMOR; CELL SURVIVAL; CHEMICAL STRUCTURE; CYTOLOGY; FEMALE; METABOLISM; TUMOR CELL LINE;

BORON COMPOUNDS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; FLUORESCENT DYES; HORMONE ANTAGONISTS; HUMANS; MIFEPRISTONE; MODELS, MOLECULAR; OPTICAL IMAGING; RECEPTORS, PROGESTERONE;

EID: 84877755692     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc3006418     Document Type: Article

References (41)

1. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R. M. (1995) The nuclear receptor superfamily: the second decade Cell 83, 835-839
2. Sladek, F. M. (2011) What are nuclear receptor ligands? Mol. Cell. Endocrinol. 334, 3-13
3. Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T., Evans, R. M., and Mangelsdorf, D. J. (2006) Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network Cell 126, 789-799
4. Conneely, O. M., Mulac-Jericevic, B., and Lydon, J. P. (2003) Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms Steroids 68, 771-778
5. Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z., and Nilsen, J. (2008) Progesterone receptors: form and function in brain Front. Neuroendocrinol. 29, 313-339
6. Obr, A. E. and Edwards, D. P. (2012) The biology of progesterone receptor in the normal mammary gland and in breast cancer Mol. Cell. Endocrinol. 357, 4-17
7. Akahira, J., Inoue, T., Suzuki, T., Ito, K., Konno, R., Sato, S., Moriya, T., Okamura, K., Yajima, A., and Sasano, H. (2000) Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies Br. J. Cancer 83, 1488-1494
8. Yang, S., Thiel, K. W., and Leslie, K. K. (2011) Progesterone: the ultimate endometrial tumor suppressor Trends Endocrinol. Metab. 22, 145-152
9. Rayasam, G. V., Elbi, C., Walker, D. A., Wolford, R., Fletcher, T. M., Edwards, D. P., and Hager, G. L. (2005) Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro Mol. Cell. Biol. 25, 2406-2418
10. Lim, C. S., Baumann, C. T., Htun, H., Xian, W., Irie, M., Smith, C. L., and Hager, G. L. (1999) Differential localization and activity of the A- and B-forms of the human progesterone receptor using green fluorescent protein chimeras Mol. Endocrinol. 13, 366-375
11. Narayanan, R., Edwards, D. P., and Weigel, N. L. (2005) Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity Mol. Cell. Biol. 25, 2885-2898
12. Leopoldo, M., Lacivita, E., Berardi, F., and Perrone, R. (2009) Developments in fluorescent probes for receptor research Drug Discovery Today 14, 706-712
13. Briddon, S. J., Kellam, B., and Hill, S. J. (2011) Design and use of fluorescent ligands to study ligand-receptor interactions in single living cells Methods Mol. Biol. 746, 211-236
14. Wang, W., Qiu, X., Zhang, F., Sun, J., Cameron, A. G., Wendt, J. A., Mawad, M. E., and Ke, S. (2011) An imageable retinoid acid derivative to detect human cancer xenografts and study therapeutic dosing to reduce its toxicity Contr. Media Mol. Imaging 6, 200-208
15. Adamczyk, M., Reddy, R. E., and Yu, Z. (2002) Synthesis of a novel fluorescent probe for estrogen receptor Bioorg. Med. Chem. Lett. 12, 1283-1285
16. Carlson, K. E., Coppey, M., Magdelenat, H., and Katzenellenbogen, J. A. (1989) Receptor binding of NBD-labeled fluorescent estrogens and progestins in whole cells and cell-free preparations J. Steroid Biochem. 32, 345-355
17. Teutsch, G., Klich, M., Bouchoux, F., Cerede, E., and Philibert, D. (1994) Synthesis of a fluorescent steroid derivative with high affinities for the glucocorticoid and progesterone receptors Steroids 59, 22-26
18. Sakai, H., Hirano, T., Mori, S., Fujii, S., Masuno, H., Kinoshita, M., Kagechika, H., and Tanatani, A. (2011) 6-arylcoumarins as novel nonsteroidal type progesterone antagonists: an example with receptor-binding-dependent fluorescence J. Med. Chem. 54, 7055-7065
19. Hodl, C., Strauss, W. S., Sailer, R., Seger, C., Steiner, R., Haslinger, E., and Schramm, H. W. (2004) A novel, high-affinity, fluorescent progesterone receptor antagonist. Synthesis and in vitro studies Bioconjugate Chem. 15, 359-365
20. Hudnall, T. W. and Gabbai, F. P. (2008) A BODIPY boronium cation for the sensing of fluoride ions Chem. Commun. 4596-4597
21. Hendricks, J. A., Keliher, E. J., Wan, D., Hilderbrand, S. A., Weissleder, R., and Mazitschek, R. (2012) Synthesis of [18F]BODIPY: bifunctional reporter for hybrid optical/positron emission tomography imaging Angew. Chem., Int. Ed. 51, 4603-4606
22. Ting, R., Aguilera, T. A., Crisp, J. L., Hall, D. J., Eckelman, W. C., Vera, D. R., and Tsien, R. Y. (2010) Fast 18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes Bioconjugate Chem. 21, 1811-1819
23. Raaijmakers, H. C., Versteegh, J. E., and Uitdehaag, J. C. (2009) The X-ray structure of RU486 bound to the progesterone receptor in a destabilized agonistic conformation J. Biol. Chem. 284, 19572-19579
24. Leonhardt, S. A. and Edwards, D. P. (2002) Mechanism of action of progesterone antagonists Exp. Biol. Med. 227, 969-980
25. Hodl, C., Raunegger, K., Strommer, R., Ecker, G. F., Kunert, O., Sturm, S., Seger, C., Haslinger, E., Steiner, R., Strauss, W. S., and Schramm, H. W. (2009) Syntheses and antigestagenic activity of mifepristone derivatives J. Med. Chem. 52, 1268-1274
26. Saha, P., Hodl, C., Strauss, W. S., Steiner, R., Goessler, W., Kunert, O., Leitner, A., Haslinger, E., and Schramm, H. W. (2010) Synthesis, in vitro progesterone receptors affinity of gadolinium containing mifepristone conjugates and estimation of binding sites in human breast cancer cells Bioorg. Med. Chem. 18, 1891-1898
27. Di Lorenzo, D., Albertini, A., and Zava, D. (1991) Progestin regulation of alkaline phosphatase in the human breast cancer cell line T47D Cancer Res. 51, 4470-4475
28. Horwitz, K. B. (1992) The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocr. Rev. 13, 146-163
29. Smith, D. F. and Toft, D. O. (2008) Minireview: the intersection of steroid receptors with molecular chaperones: observations and questions Mol. Endocrinol. 22, 2229-2240
30. Pratt, W. B., Morishima, Y., and Osawa, Y. (2008) The Hsp90 chaperone machinery regulates signaling by modulating ligand binding clefts J. Biol. Chem. 283, 22885-22889
31. Smith, D. F., Stensgard, B. A., Welch, W. J., and Toft, D. O. (1992) Assembly of progesterone receptor with heat shock proteins and receptor activation are ATP mediated events J. Biol. Chem. 267, 1350-1356
32. Segnitz, B. and Gehring, U. (1997) The function of steroid hormone receptors is inhibited by the hsp90-specific compound geldanamycin J. Biol. Chem. 272, 18694-18701
33. Zajac, M., Gomez, G., Benitez, J., and Martinez-Delgado, B. (2010) Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer. BMC Med. Genomics 3, 44
34. Bali, P., Pranpat, M., Bradner, J., Balasis, M., Fiskus, W., Guo, F., Rocha, K., Kumaraswamy, S., Boyapalle, S., Atadja, P., Seto, E., and Bhalla, K. (2005) Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors J. Biol. Chem. 280, 26729-26734
35. Hernandez, M. P., Chadli, A., and Toft, D. O. (2002) HSP40 binding is the first step in the HSP90 chaperoning pathway for the progesterone receptor J. Biol. Chem. 277, 11873-11881
36. Williamson, D. S., Borgognoni, J., Clay, A., Daniels, Z., Dokurno, P., Drysdale, M. J., Foloppe, N., Francis, G. L., Graham, C. J., Howes, R., Macias, A. T., Murray, J. B., Parsons, R., Shaw, T., Surgenor, A. E., Terry, L., Wang, Y., Wood, M., and Massey, A. J. (2009) Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design J. Med. Chem. 52, 1510-1513
37. Wang, A. M., Morishima, Y., Clapp, K. M., Peng, H. M., Pratt, W. B., Gestwicki, J. E., Osawa, Y., and Lieberman, A. P. (2010) Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation J. Biol. Chem. 285, 15714-15723
38. Davies, T. H. and Sanchez, E. R. (2005) Fkbp52 Int. J. Biochem. Cell Biol. 37, 42-47
39. Le Bihan, S., Marsaud, V., Mercier-Bodard, C., Baulieu, E. E., Mader, S., White, J. H., and Renoir, J. M. (1998) Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells Mol. Endocrinol. 12, 986-1001
40. Uotinen, N., Puustinen, R., Pasanen, S., Manninen, T., Kivineva, M., Syvala, H., Tuohimaa, P., and Ylikomi, T. (1999) Distribution of progesterone receptor in female mouse tissues Gen. Comp. Endrocrinol. 115, 429-441
41. Heikinheimo, O., Pesonen, U., Huupponen, R., Koulu, M., and Lahteenmaki, P. (1994) Hepatic metabolism and distribution of mifepristone and its metabolites in rats Hum. Reprod. 9 (Suppl 1) 40-46